Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zolmitriptan, quantity: 2.5 mg - tablet, film coated - excipient ingredients: lactose; magnesium stearate; microcrystalline cellulose; sodium starch glycollate type a; titanium dioxide; hypromellose; macrogol 6000; iron oxide red; macrogol 400 - for the acute treatment of migraine with or without aura.

Australia - inglese - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - zolmitriptan, quantity: 2.5 mg - tablet, film coated - excipient ingredients: microcrystalline cellulose; sodium starch glycollate type a; lactose; magnesium stearate; titanium dioxide; hypromellose; macrogol 6000; iron oxide red; macrogol 400 - for the acute treatment of migraine with or without aura.

Canada - inglese - Health Canada

ratiopharm inc division of teva canada limited - zolmitriptan - tablet (immediate release) - 2.5mg - zolmitriptan 2.5mg - selective serotonin agonists

Canada - inglese - Health Canada

ratiopharm inc division of teva canada limited - zolmitriptan - tablet (orally disintegrating) - 2.5mg - zolmitriptan 2.5mg - selective serotonin agonists

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - zolmitriptan - orodispersible tablet - 2.5mg

Regno Unito - inglese - MHRA (Medicines & Healthcare Products Regulatory Agency)

accord-uk ltd - zolmitriptan - orodispersible tablet - 5mg

Stati Uniti - inglese - NLM (National Library of Medicine)

alembic pharmaceuticals limited - zolmitriptan (unii: 2fs66th3yw) (zolmitriptan - unii:2fs66th3yw) - zolmitriptan is indicated for the acute treatment of migraine with or without aura in adults limitations of use - only use zolmitriptan if a clear diagnosis of migraine has been established. if a patient has no response to zolmitriptan treatment for the first migraine attack, reconsider the diagnosis of migraine before zolmitriptan is administered to treat any subsequent attacks. - zolmitriptan is not indicated for the prevention of migraine attacks. - safety and effectiveness of zolmitriptan have not been established for cluster headache. zolmitriptan is contraindicated in patients with: - ischemic coronary artery disease (angina pectoris, history of myocardial infarction, or documented silent ischemia), other significant underlying cardiovascular disease, or c oronary artery vasospasm including prinzmetal’s angina [see warnings and precautions (5.1) ] - wolff-parkinson-white syndrome or arrhythmias associated with other cardiac accessory conduction pathway disorders [see   warnings and precautions (5.2) ] -

Canada - inglese - Health Canada

jubilant generics limited - zolmitriptan - tablet (orally disintegrating) - 2.5mg - zolmitriptan 2.5mg - selective serotonin agonists

Canada - inglese - Health Canada

sanis health inc - zolmitriptan - tablet - 2.5mg - zolmitriptan 2.5mg - selective serotonin agonists

Canada - inglese - Health Canada

sanis health inc - zolmitriptan - tablet (orally disintegrating) - 2.5mg - zolmitriptan 2.5mg - selective serotonin agonists